Loading...
XHELOKDBV
Market cap171mUSD
Dec 20, Last price  
0.90EUR
1D
-0.99%
1Q
-2.50%
Jan 2017
-79.21%
IPO
-55.42%
Name

Oriola Oyj

Chart & Performance

D1W1MN
XHEL:OKDBV chart
P/E
—
P/S
0.11
EPS
—
Div Yield, %
6.67%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
-0.76%
Revenues
1.49b
-1.43%
662,700,0001,377,300,0001,580,800,0001,713,100,0001,929,400,0002,146,000,0002,474,400,0002,598,500,0001,612,300,0001,626,300,0001,642,100,0001,527,700,0001,552,200,0001,721,300,0001,800,800,0001,882,400,0001,515,500,0001,493,800,000
Net income
-21m
L
9,600,00023,300,00027,500,00048,600,000102,100,000-24,100,00017,200,0005,800,000-212,300,00044,600,00042,800,00026,300,00012,700,0008,000,00011,300,00011,300,0004,800,000-20,700,000
CFO
10m
-87.68%
46,100,00039,000,000-18,100,000100,900,00088,700,00028,100,00046,100,00029,800,000-10,800,00085,600,00040,100,00023,700,000102,800,00084,400,00058,300,00040,000,00077,900,0009,600,000
Dividend
Mar 20, 20240.07 EUR/sh
Earnings
Feb 14, 2025

Profile

Oriola Oyj provides healthcare and wellbeing products in Sweden, Finland, and internationally. The company offers over the counter (OTC) pharmaceutical and traded goods, vitamins, dietary supplements, cosmetics, skincare products, sports drinks, and wound care products. It also provides logistics, advisory, sales and marketing, and expert services for pharmaceutical companies, pharmacies, hospital pharmacies, veterinaries, as well as the grocery trade shops. In addition, the company offers pharmaceutical staffing and dose dispensing services for public and private healthcare operators, pharmacies, groceries, veterinarians, and retailers. As of December 31, 2021, it operated 319 pharmacies in Sweden, as well as operates online pharmacies. The company was formerly known as Oriola-KD Oyj and changed its name to Oriola Oyj in April 2017. Oriola Oyj is headquartered in Espoo, Finland.
URL
https://www.oriola.com/
IPO date
Jul 03, 2006
Employees
797
Domiciled in
FI
Incorporated in
FI

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,493,800
-1.43%
1,515,500
-19.49%
1,882,400
4.53%
Cost of revenue
1,480,300
1,330,200
1,509,400
Unusual Expense (Income)
NOPBT
13,500
185,300
373,000
NOPBT Margin
0.90%
12.23%
19.82%
Operating Taxes
3,100
2,100
3,400
Tax Rate
22.96%
1.13%
0.91%
NOPAT
10,400
183,200
369,600
Net income
(20,700)
-531.25%
4,800
-57.52%
11,300
0.00%
Dividends
(10,900)
(7,300)
(5,400)
Dividend yield
5.32%
2.18%
1.48%
Proceeds from repurchase of equity
(100)
(100)
(100)
BB yield
0.05%
0.03%
0.03%
Debt
Debt current
110,700
55,200
70,400
Long-term debt
16,000
84,300
202,300
Deferred revenue
1
18,000
Other long-term liabilities
14,300
12,400
400
Net debt
(260,700)
(295,700)
129,400
Cash flow
Cash from operating activities
9,600
77,900
40,000
CAPEX
(3,600)
(8,500)
(23,400)
Cash from investing activities
(3,500)
3,000
9,600
Cash from financing activities
(28,300)
(29,300)
(108,500)
FCF
85,400
162,100
418,500
Balance
Cash
138,400
160,600
109,100
Long term investments
249,000
274,600
34,200
Excess cash
312,710
359,425
49,180
Stockholders' equity
171,300
225,700
216,800
Invested Capital
132,100
130,600
374,320
ROIC
7.92%
72.57%
100.44%
ROCE
4.41%
51.30%
85.69%
EV
Common stock shares outstanding
181,423
181,423
181,423
Price
1.13
-38.75%
1.85
-7.98%
2.01
5.42%
Market cap
205,007
-38.75%
334,725
-7.98%
363,752
5.39%
EV
(55,693)
39,025
493,152
EBITDA
27,300
203,600
416,100
EV/EBITDA
0.19
1.19
Interest
9,200
2,200
4,000
Interest/NOPBT
68.15%
1.19%
1.07%